Eyelid margin disease (blepharitis and meibomian gland dysfunction): clinical review of evidence-based and emerging treatments.
Rocha KM, Farid M, Raju L, Beckman K, Ayres BD, Yeu E, Rao N, Chamberlain W, Zavodni Z, Lee B, Schallhorn J, Garg S, Mah FS; From the ASCRS Cornea Clinical Committee.
J Cataract Refract Surg. 2024 Aug 1;50(8):876-882. doi: 10.1097/j.jcrs.0000000000001414.
Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies.
Rhee MK, Yeu E, Barnett M, Rapuano CJ, Dhaliwal DK, Nichols KK, Karpecki P, Mah FS, Chan A, Mun J, Gaddie IB.
Eye Contact Lens. 2023 Aug 1;49(8):311-318. doi: 10.1097/ICL.0000000000001003. Epub 2023 Jun 2.
Ocular manifestations of rosacea: A clinical review.
Tavassoli S, Wong N, Chan E.
Clin Exp Ophthalmol. 2021 Mar;49(2):104-117. doi: 10.1111/ceo.13900. Epub 2021 Feb 3.
Allergic disorders of the eyelid.
Hine AM, Waldman RA, Grzybowski A, Grant-Kels JM.
Clin Dermatol. 2023 Jul-Aug;41(4):476-480. doi: 10.1016/j.clindermatol.2023.08.002. Epub 2023 Sep 15.
Update on the Management of Demodex Blepharitis.
Shah PP, Stein RL, Perry HD.
Cornea. 2022 Aug 1;41(8):934-939. doi: 10.1097/ICO.0000000000002911. Epub 2021 Nov 3.
Ocular Rosacea: An Updated Review.
Mohamed-Noriega K, Loya-Garcia D, Vera-Duarte GR, Morales-Wong F, Ortiz-Morales G, Navas A, Graue-Hernandez EO, Ramirez-Miranda A.
Cornea. 2025 Apr 1;44(4):525-537. doi: 10.1097/ICO.0000000000003785. Epub 2025 Jan 14.
Current state and future perspectives in the diagnosis of eyelid margin disease: clinical review.
Yeu E, Garg S, Ayres BD, Beckman K, Chamberlain W, Lee B, Raju L, Rao N, Rocha KM, Schallhorn J, Zavodni Z, Mah FS, Farid M; from the ASCRS Cornea Clinical Committee.
J Cataract Refract Surg. 2024 Aug 1;50(8):868-875. doi: 10.1097/j.jcrs.0000000000001483.
Blepharitis.
Bernardes TF, Bonfioli AA.
Semin Ophthalmol. 2010 May;25(3):79-83. doi: 10.3109/08820538.2010.488562.
Blepharitis and Neoplasms of the Canine Eyelid Margin and Skin.
Grahn B.
Vet Clin North Am Small Anim Pract. 2023 Mar;53(2):455-471. doi: 10.1016/j.cvsm.2022.11.002.
Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
Gaddie IB, Donnenfeld ED, Karpecki P, Vollmer P, Berdy GJ, Peterson JD, Simmons B, Edell ARP, Whitson WE, Ciolino JB, Baba SN, Holdbrook M, Trevejo J, Meyer J, Yeu E; Saturn-2 Study Group.
Ophthalmology. 2023 Oct;130(10):1015-1023. doi: 10.1016/j.ophtha.2023.05.030. Epub 2023 Jun 5.
